Immunotherapy Manufacturers, Suppliers & Companies (Medical Specialties)
-
Manufacturerbased in Vienna, AUSTRIA
Privately held OncoQR ML, based in Vienna/Austria, is a pre-clinical biotech company that offers novel therapeutic cancer vaccines based on its unique, proprietary and broadly applicable S-TIR™ (Specific Total Immune Remodulation) technology ...
Cancer Immunotherapy Technology
Cancer cells have the ability to escape our immune system´s defenses – by outsmarting checkpoint molecules on our immune cells. For more than three decades, science and industry have been working to overcome cancer’s tricky battle ...
CONTACT SUPPLIER -
Manufacturerbased in Emeryville, CALIFORNIA (USA)
Dynavax is a commercial stage biopharmaceutical company committed to developing and commercializing novel vaccines to help protect the world against infectious diseases, by utilizing proven, innovative adjuvant technology. Our vision and work ethic ...
-
Publishing companybased in London, UNITED KINGDOM
Informa is a leading business intelligence, academic publishing, knowledge and events business, operating within the Knowledge and Information Economy. We serve commercial, professional and academic communities in many different sectors by helping ...
-
Manufacturerbased in Charlottesville, VIRGINIA (USA)
LumaCyte is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation where the use of antibody or genetic labeling is not required for cellular analysis. This revolutionary ...
-
Manufacturerbased in New York, NEW YORK (USA)
Intrommune is a New York City-based biotechnology company dedicated to simplifying allergy immunotherapy. Intrommune’s core technology enables immunotherapeutic agents to be delivered in a specially formulated toothpaste designed to incorporate and ...
Intrommune - Model OMIT - Oral Mucosal Immunotherapy for the Treatment of Food Allergies
Intrommune has developed a novel drug delivery platform—oral mucosal immunotherapy (OMIT)—for the treatment of food allergies. Therapeutic agents are embedding in fully functioning toothpaste so that treatment can be conveniently ...
CONTACT SUPPLIER -
Manufacturerbased in New York City, NEW YORK (USA)
Allovate Therapeutics is a specialty biopharmaceutical company dedicated to simplifying allergy treatment by providing safe, effective, and convenient new options for allergy sufferers. Oral mucosal immunotherapy (OMIT) is a novel form of ...
Allovate - Model OMIT - Oral Mucosal Immunotherapy
Oral mucosal immunotherapy (OMIT) is a novel form of allergen-specific immunotherapy. Immunotherapy has a 100-year track record of success for respiratory allergies. OMIT improves upon this approach by delivering immunotherapeutic agents to the ...
CONTACT SUPPLIER -
Manufacturerbased in Waltham, MASSACHUSETTS (USA)
AlloVir is the global leader in developing VST immunotherapies. We develop highly innovative, allogeneic, off-the-shelf, virus-specific T cell (VST) therapies designed to prevent and treat life-threatening viral diseases. AlloVir is a leading late ...
-
Manufacturerbased in Cantanhede, PORTUGAL
For a safer tomorrow developing immunotherapies to address life threatening bacterial infections. Immunethep is a biotech startup company (spin-off from the University of Porto) that is developing anti-bacterial immunotherapies based on the ...
Immunethep - Anti-Bacterial Immunotherapy
Immunethep has developed an anti-bacterial immunotherapy based on the discovery of a virulence mechanism shared by a set of different pathogenic ...
CONTACT SUPPLIER -
Manufacturerbased in Southampton, UNITED KINGDOM
Synairgen is a drug discovery and development company founded by University of Southampton Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on COVID-19, severe asthma and COPD, discovers and develops ...
Programmes & Clinical Trials Services
Synairgen's primary focus is the development of its inhaled interferon-beta product SNG001, to meet the urgent need for the treatment of severe viral lung infections, including COVID-19, as potentially the first host-directed, broad-spectrum ...
CONTACT SUPPLIER -
Technologybased in São Paulo, BRAZIL
Celluris is the first company in Latin America to develop personalized treatment for cancer patients through CAR-T immunotherapy. This technique is based on the modification of the patient’s own cells into recognizing the tumor as a target, fighting ...
Model CAR-T - Chimeric T Cell Antigen Receptor Therapy
The chimeric T cell antigen receptor therapy, also known as CAR-T, is an immunotherapy that is innovating the treatment of hematological and solid tumors. This new technology is considered less aggressive than conventional treatments, since it ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you